Friedrich Graf Finckenstein - 14 Jun 2022 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role: Chief Medical Officer
Signature: /s/ Friedrich Graf Finckenstein
Issuer symbol: IOVA
Transactions as of: 14 Jun 2022
Net transactions value: -$52,634
Form type: 4
Filing time: 16 Jun 2022, 17:04:16 UTC
Previous filing: 19 Jan 2022
Next filing: 05 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IOVA	Common Stock	Options Exercise	$0	+19,690		$0.000000	19,690	14 Jun 2022	Direct	F1
transaction	IOVA	Common Stock	Tax liability	$52,634	-6,809	-35%	$7.73	12,881	14 Jun 2022	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IOVA	Restricted Stock Units	Award	$0	+19,690		$0.000000	19,690	14 Jun 2022	Common stock	19,690		Direct	F4, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This is the first vesting of the restricted stock units issued on June 14, 2021.
F2	Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities.
F3	Represents the common stock remaining after deducting the common stock withheld for taxes.
F4	Represents restricted stock units remaining after deducting the vested shares of common stock and the common stock withheld for taxes as set forth in Table I above.
F5	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F6	Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date.